Despite the relative overexpression of collagen VI genes in RA, we hypothesised that the accompanying overexpression of MMP2 and MMP9 in active disease, contrasting with the overexpression of their inhibitor TIMP3 in remission, would contribute to net protein deposition in the remission phases of disease. The gene discussed is MMP9; the disease is rheumatoid arthritis.